Claimed are intermediates in the synthesis of N-Arylmethyl-3-Oxo-2,3-dihydro- [1,2,4]triazolo[4,3-a]pyridine-6-carboxamides as well as a process (A) to arrive at 3-Oxo-2, 3-dihydro-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid. The triazolo[4,3-a]pyridine-6-carboxamides of formula (I) are used as soluble epoxide hydrolase inhibitors (sEH) having therapeutic effect in pathologic conditions such as hypertension, stroke, inflammatory processes, diabetes and a variety of cardiovascular diseases.
所述
中间体是合成N-芳基
甲基-3-
氧代-2,3-二
氢-[1,
2,4]三唑[4,3-a]
吡啶-6-羧
酰胺以及到达3-
氧代-2,3-二
氢-[1,
2,4]三唑[4,3-a]
吡啶-6-
羧酸的过程(A)的
中间体。式(I)的三唑[4,3-a]
吡啶-6-羧
酰胺被用作可溶性环
氧化酶
抑制剂(sEH),在高血压、中风、炎症过程、糖尿病和各种心血管疾病等病理条件中具有治疗效果。